Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Nanomedicine. 2017 Jul 1;13(7):2313–2324. doi: 10.1016/j.nano.2017.06.017

TABLE 1.

Encapsulated concentrations, encapsulation efficiency (EE), and payload for 5-FU, ATP:5-FU, FUdR, FdUMP, dFdC or dFdCMP in citrate-functionalized (Cit) CPSNPs.

Formulation Drug Concentration (M)* EE (mol%)* Calculated Payload (molecules/nm3 CPSNP×10−1)
Cit-5-FU-CPSNP 4.1 (±1.8) ×10−7 0.11 (±0.04) 0.10 (±0.07)
Cit-ATP:5-FU-CPSNP 1.8 (±2.5) ×10−6 0.36 (±0.39) 0.47 (±0.54)
Cit-FUdR-CPSNP 2.8 (±1.2) ×10−8 <0.01 0.07 (±0.03)
Cit-FdUMP-CPSNP 3.0 (±1.4) ×10−4 41 (±16) 32 (±16)
Cit-dFdC-CPSNP 1.9 (±0.6) ×10−9 <0.01 0.01 (±0.01)
Cit-dFdCMP-CPSNP 2.3 (±0.4) ×10−5 22 (±6) 3.6 (±1.6)
*

Expressed as the mean ±95% CI of n=4–6 experimental replicates.

Particle number concentration by volume (particles/ml) is listed in Table S1 of supplementary information.